My name is Reta Bodagh and I am a graduate of the MBiotech Program, class of 2022. I specialized in Molecular Biology for my undergraduate studies at the University of Toronto. My love for all-things science led me to undertake various research opportunities and pursue a Master of Science, focusing on anti-cancer therapies. Intrigued by all the possibilities of innovative medicine, I wanted to broaden my horizons and learn more about the pharmaceutical industry. So, I pursued the MBiotech Program which offers a unique blend of science and business and an unmatched network of professionals in the biotechnology space. I started my industry journey at Roche as a Policy and Market Access Intern. In this role, I broadened my understanding of government relations, healthcare policy, and the value of innovative medicines. I then transitioned to the medical team at Roche, working as an Evidence Generation Associate and later, Evidence Operations Manager. In these roles, I contributed to the design and execution of real-world studies in Alzheimer's disease, oncology, and ophthalmology. Today, as a Patient Services Senior Manager at Alexion Pharmaceuticals, I lead Patient Support Programs (PSPs) across multiple rare diseases. I aim to transform the journey of patients living with rare diseases by combining strategy, operational excellence, and patient-centricity in designing, launching, and maintaining PSPs. I am excited to continue advancing in this exciting sector to catalyze positive healthcare change!
How did your experience in the MBiotech program contribute to your career success?
The MBiotech program provided me with a solid grasp of both science and business, emphasizing scientific advancements and innovative approaches for today’s dynamic landscape. Additionally, the teamwork aspect of the Program prepared me for the collaborative nature of industry, providing practical experiences that molded my teamwork, communication and leadership abilities. Lastly, the Program introduced me to an unmatched network of MBiotechers - a supportive community of professionals always ready to share insights and assist in navigating the evolving challenges of our field.
What are some of the key skills and knowledge you acquired during the MBiotech program that are still valuable to you today?
The skills and knowledge I gained in the MBiotech Program still hold immense value for me today, especially in aspects like teamwork, communication, and critical thinking.
What advice would you give to current MBiotech students or recent graduates who are entering the job market?
My advice to current MBiotech students and recent graduates is to stay curious, be open to continuous learning, cherish the relationships built during the Program, and continue building a supportive network of MBiotechers and industry colleagues.
